Karpus files 13G/A reporting 0 shares owned
GP-Act III Acquisition Corp. amendment to its Schedule 13G/A states that Karpus Management, Inc. reports 0.00 shares beneficially owned of Common Stock (CUSIP G4035N103), representing 0.00% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GP-Act III Acquisition Corp. amendment to its Schedule 13G/A states that Karpus Management, Inc. reports 0.00 shares beneficially owned of Common Stock (CUSIP G4035N103), representing 0.00% of the class. The filing is signed by the Chief Compliance Officer on 06/05/2026.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficially owned regulatory
CUSIP financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Karpus Management report for GPAT in this Schedule 13G/A?
Who signed the Schedule 13G/A for Karpus and when was it signed?
What is the issuer and CUSIP referenced in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.